[Corrigendum] TUSC8 inhibits the development of osteosarcoma by sponging miR‑197‑3p and targeting EHD2

Fan,Hongwu; Liu,Tong; Tian,Hao; Zhang,Shanyong

doi:10.3892/ijmm.2021.4891

April-2021 Volume 47 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2021 Volume 47 Issue 4

Full Size Image

Correction Open Access

[Corrigendum] TUSC8 inhibits the development of osteosarcoma by sponging miR‑197‑3p and targeting EHD2

Authors:
- Hongwu Fan
- Tong Liu
- Hao Tian
- Shanyong Zhang
View Affiliations / Copyright

Affiliations: Department of Orthopaedics, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Spine Surgery, The Second Hospital of Jilin University, Changchun, Jilin 130000, P.R. China

Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 58
|
Published online on: February 18, 2021

https://doi.org/10.3892/ijmm.2021.4891
Expand metrics +

Article

Int J Mol Med 46: [Related article:] 1311-1320, 2020; DOI: 10.3892/ijmm.2020.4684

Subsequently to the publication of this article, the authors have realized that Fig. 2D contained a duplication error, which arose during the assembly of the figures; specifically, the upper-left panel in Fig. 2D, showing the results of the MG-63/pcDNA3.1 Transwell assay experiment, were inadvertently repeated in Fig. 5E. The corrected version of Fig. 2, showing the correct data for Fig. 2D, is shown on the next page.

Figure 5

TUSC8 inhibits OS development by regulating EHD2. (A) The mRNA and protein levels of EHD2 were evaluated in sh-EHD2-transfected cells. (B and C) CCK-8 and colony formation assays were used to assess cell proliferation in transfected cells. (D) Flow cytometry was used to measure cell apoptosis. (E and F) Transwell assays were carried out to evaluate cell migration and invasion. (G) Western blot analysis was used to evaluate epithelial-mesenchymal transition. *P<0.05 and &P<0.05.

The authors wish to emphasize that this correction does not change either the interpretation or the original conclusions of their study. The authors are grateful to the Editor of International Journal of Molecular Medicine for granting them the opportunity to publish this corrigendum, and all the authors agree with the correction. Furthermore, the authors apologize to the Editor of International Journal of Molecular Medicine and to readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] TUSC8 inhibits the development of osteosarcoma by sponging miR‑197‑3p and targeting EHD2

This article is mentioned in:

Article

Figure 5

Figure 5

Related Articles